Volume 01 · Research Brief

Control the variables. Control the fight.

Independent research on peptides, recovery, performance, and longevity. No hype, no shortcuts — just the literature, distilled.

07
Categories
21
Articles
Weekly
Updated
Featured

Editor selections

Latest

From the lab notebook

Cover image for BPC-157 Recovery Guide: What the Research Actually Supports
Peptide Research8 min read

BPC-157 Recovery Guide: What the Research Actually Supports

BPC-157 dominates the peptide recovery conversation, but most of the evidence is preclinical. Here is a calm, research-grounded look at what the studies really show — and what is being sold ahead of them.

Jul 25, 2026Read
Cover image for Heart Rate Variability: What It Measures and What It Misses
Performance & Growth8 min read

Heart Rate Variability: What It Measures and What It Misses

HRV is one of the most useful — and most misinterpreted — recovery metrics available. Here is a comprehensive look at what it measures, what it does not, and how to actually use it.

Jul 18, 2026Read
Cover image for The Mechanism of Novelty: Understanding Dopamine Dynamics in the Digital Age
Cognitive & Wellness7 min read

The Mechanism of Novelty: Understanding Dopamine Dynamics in the Digital Age

An exploration of how the brain processes novelty and why modern digital environments may be precipitating a systemic decline in sustained attentional capacity.

Jul 18, 2026Read
Cover image for Heart Rate Variability: The Physiology of the Autonomic Stress Signal
Performance & Growth8 min read

Heart Rate Variability: The Physiology of the Autonomic Stress Signal

HRV is one of the most useful — and most misinterpreted — recovery metrics available. Here is a comprehensive look at what it measures, what it does not, and how to actually use it.

Jul 18, 2026Read
Cover image for Retatrutide (R3TA): What the Triple Agonist Research Actually Shows
Weight Management & Metabolism16 min read

Retatrutide (R3TA): What the Triple Agonist Research Actually Shows

Retatrutide is the first investigational triple agonist targeting GLP-1, GIP, and glucagon. A close read of the Phase 2 data — mechanism, weight loss, side effects, and the questions Phase 3 still has to answer.

Jun 25, 2026Read
Cover image for Insulin Sensitivity and the Pre-Diabetic Window Most People Miss
Weight Management & Metabolism13 min read

Insulin Sensitivity and the Pre-Diabetic Window Most People Miss

Fasting glucose is the last metric to change. Here is a comprehensive look at insulin sensitivity, the pre-diabetic window most people miss, and the evidence-based levers that actually move the needle.

Jun 25, 2026Read
Subscribe

Weekly research, in your inbox.

Get one carefully edited dispatch each week — the most important peptide, performance, and longevity research, distilled into something you can use.

Prefer a starting point? Grab the free 30 Peptides Codex →

Research library

A curated stack

Mechanism deep-dives

Pathway-level breakdowns of the most-studied peptides and protocols.

Annotated literature

Editor-tagged papers with practical translations of the findings.

Protocol benchmarks

What is working, what failed replication, and what to actually try.

FAQ

Common questions

What does Control The Fight cover?

Independent, editor-reviewed research on peptides, recovery, performance, metabolism, cognition, and longevity — distilled from the primary literature into practical briefings.

Is this medical advice?

No. Everything published on Control The Fight is educational reporting on published research. Speak with a qualified clinician before starting any protocol.

How often is new research published?

A new dispatch goes out weekly to newsletter subscribers, with additional briefings and category updates published throughout the month.

What is the free 30 Peptides Codex?

A curated reference guide to 30 of the most-studied peptides — mechanisms, evidence quality, and use-cases — free to every newsletter subscriber.